Ovarian cancer study aims to match patients to best treatment with new tests
NCT ID NCT06152731
First seen Oct 01, 2025 · Last updated May 16, 2026 · Updated 21 times
Summary
This study looks at 88 women with advanced ovarian cancer to compare two tests that check for a DNA repair problem called HRD. The tests help doctors see if the cancer is likely to respond to platinum chemotherapy and if a PARP inhibitor drug might help. The goal is to learn which test works best to guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Francois Baclesse
RECRUITINGCaen, France
Contact
-
Centre Henri Becquerel
RECRUITINGRouen, France
Contact
-
Centre Oscar Lambret
RECRUITINGLille, France
Contact
-
Chu Amiens
NOT_YET_RECRUITINGAmiens, France
Contact
Conditions
Explore the condition pages connected to this study.